If you're an investor looking to grow your long-term passive income prospects, the five stocks in this article could be perfect to add to your portfolio before 2025.
One of my favorite ways to add money to my portfolio is to invest in proven compounders with track records of delivering market-beating results after short-term pullbacks. This idea is especially true...
/Zoetis%20Inc%20HQ%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Zoetis has recently underperformed the broader healthcare sector, but analysts remain optimistic about its long-term growth prospects.
Robert J Polzer, the Executive Vice President of $ZTS ($ZTS), sold 3,477 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 51.7%...
Brokerage firm Morgan Stanley is bullish on cyclical stocks.
Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Reception to recent US election results has been mixed within the agriculture sector, with enthusiasm from some and...
Zoetis has significantly underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.
Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip.
ZTS earnings call for the period ending September 30, 2024.